Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that 95% pure EGCG can protect brain cells in patients with Multiple
Sclerosis. To test this hypothesis we are going to compare the changes in n-Acetyl-Aspartate
(a chemical that reflects the number of neurons and their metabolism) over one six between
people with MS treated with EGCG at a dose of 400mg twice a day and people with MS treated
with a matching sugar pill.
Phase:
Phase 2
Details
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans